- Home
- MLSS vs INMB Comparison
MLSS vs INMB Comparison
Compare MLSS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLSS | INMB |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 49.2M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MLSS | INMB |
|---|---|---|
| Price | $0.36 | $1.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $4.30 |
| AVG Volume (30 Days) | ★ 3.2M | 433.3K |
| Earning Date | 11-13-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,929,517.00 | $50,000.00 |
| Revenue This Year | $8.95 | $173.21 |
| Revenue Next Year | $7.51 | $12,733.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.59 | ★ 19.05 |
| 52 Week Low | $0.28 | $1.38 |
| 52 Week High | $1.39 | $11.64 |
Technical Indicators
Market Signals| Indicator | MLSS | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 63.40 |
| Support Level | $0.31 | $1.54 |
| Resistance Level | $0.32 | $1.75 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 85.05 | 98.08 |
Price Performance
Historical ComparisonAbout MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.